
M&A in Crypto Market
Explore how a volatile market and intensifying regulatory landscape is affecting deal making within a fast-growing crypto sector.

Is Regulation Making M&A Harder?
Explore how multinational corporations and private equity firms can navigate and prepare for an increasingly complex regulatory landscape.

Healthtech and Biotech M&A
The healthcare tech and biotech industries shifted fundamentally during the pandemic. Enthusiasm for dealmaking continues to be a growth area.

Tech M&A Outlook
After a pullback in tech M&A in 2022, and with IPO markets sluggish, dealmakers expect an uptick in M&A activity in 2023.

Cross-Border Dealmaking
The M&A landscape has shifted this year to take account of more strategic concerns. Companies are focused on supply chain disruption, inflation and geopolitical unrest, creating interesting opportunities for buyers.